BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies. (Record no. 23474003)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02203 a2200649 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516192801.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201410s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1476-5551 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/leu.2014.44 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bogenberger, J M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20141007 |
| 245 00 - TITLE STATEMENT | |
| Title | BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Leukemia |
| Date of publication, distribution, etc. | Aug 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1657-65 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antimetabolites, Antineoplastic |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Azacitidine |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biphenyl Compounds |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bridged Bicyclo Compounds, Heterocyclic |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Myeloid, Acute |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Myelodysplastic Syndromes |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Myeloid Cell Leukemia Sequence 1 Protein |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Myeloproliferative Disorders |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nitrophenols |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Piperazines |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proto-Oncogene Proteins c-bcl-2 |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | RNA Interference |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulfonamides |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | bcl-X Protein |
| General subdivision | antagonists & inhibitors |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kornblau, S M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pierceall, W E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lena, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chow, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shi, C-X |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mantei, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ahmann, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gonzales, I M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Choudhary, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Valdez, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Camoriano, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fauble, V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tiedemann, R E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Qiu, Y H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Coombes, K R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cardone, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Braggio, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yin, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Azorsa, D O |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mesa, R A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stewart, A K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tibes, R |
| 773 0# - HOST ITEM ENTRY | |
| Title | Leukemia |
| Related parts | vol. 28 |
| -- | no. 8 |
| -- | p. 1657-65 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/leu.2014.44">https://doi.org/10.1038/leu.2014.44</a> |
| Public note | Available from publisher's website |
No items available.